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The highly successful epidemic of healthcare-associated methicillin-resistant
Staphylococcus aureus (HA-MRSA) ST239 is a growing concern worldwide, due
to its progressive adaptation to the highly selective environment of the healthcare
system. HA-MRSA ST239 display the reduced virulence and successfully colonize
in hospital settings, while the emergent community-associated MRSA (CA-MRSA)
maintain full virulence and cause infections in the community environment. Our aim
was to investigate what enables S. aureus ST239 to be highly adaptive under hospital
circumstances and gradually progress to a series of widespread invasive infections.
We found that spa expression of HA-MRSA ST239 is much higher than that of CA-SA
ST398. And we discovered that the highly production of staphylococcal protein A
(SpA), having no concern with spa gene structure, enhances nasal colonization and cell
adhesion in ST239. S. aureus ST239 defends against the adaptive immune response
by resisting phagocytosis and inducing apoptosis of B cells through expression of
surface-anchored and released protein A, facilitating its dissemination within the
circulatory system to other organs. Protein A also plays another key role in subverting
the host immune response through its ability to induce early shedding of TNF-α receptor
1 (TNFR1) from phagocytic cells. The increased levels of soluble TNFR1 present during
experimental S. aureus ST239 infection may neutralize circulating TNF-α and impair
the host inflammatory response. Protein A is also a virulence factor, as tested in our
bacteremia model in mice, contributing to the durative tissue damage of abscess
formation sites in ST239 infection. These functions of protein A eventually benefit to
widespread infections of S. aureus ST239. We draw the conclusion that Staphylococcal
Protein A may be a crucial determinant in the colonization and immune evasion of
ST239 infections, contributing to persistent spread in the hospital settings. These results
suggest that antibodies against protein A may provide insights into the development of
novel treatments against S. aureus, especially HA-MRSA.
Keywords: healthcare-associated methicillin-resistant Staphylococcus aureus, protein A, colonization, adhesion,
immune evasion
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INTRODUCTION
Staphylococcus aureus is a significant pathogen causing a series of
infections, both in and out of the hospital settings. Under high
antibiotic selective pressure, S. aureus has evolved its own tactics
for survival and rapidly developed into a multidrug-resistant
pathogen, especially methicillin-resistant S. aureus (MRSA). The
overall number of invasive MRSA infections was estimated
to be 80,461 within the United States alone in 2011 (Dantes
et al., 2013). Notably, ∼20% of the healthy human population
also has continuous nasal cavity colonization with S. aureus,
which constitutes a major risk for opportunistic infections
(Weidenmaier et al., 2012).
The challenge of MRSA is an international health issue, and
Asia is amongst the regions with the highest prevalence rates
of healthcare-associated (HA)-MRSA and community-associated
(CA)-MRSA in the world (Chen and Huang, 2014). MRSA
prevalence in China has reached 50 to 70% of total S. aureus
isolates (Liu et al., 2009; Xiao et al., 2011). Laboratory-based
surveillance studies have shown that ST239-SCCmecIII is the
most common HA-MRSA clone in a number of geographically
dispersed Chinese hospitals, with ST5-SCCmecII being the
second most common (Li et al., 2013; Xiao et al., 2013). In
contrast, the major strain of CA-MRSA is ST59-SCCmecIV in
children (Geng et al., 2010) and there is also an international
emerging spread of livestock-associated MRSA ST398 between
humans and animals, and also between humans and humans
(Huijsdens et al., 2006; van Belkum et al., 2008; Wang et al.,
2015). In mainland China, the most prevalent CA-SA clone in
adult skin and soft tissue infections is ST398, having no apparent
association with animal contact (Zhao et al., 2012). The highly
successful infiltration and adaptation into the hospital setting
of MRSA ST239 is globally well known, with its earliest reports
being in the late 1970s in the United Kingdom and the United
States (Cookson and Phillips, 1988; Dubin et al., 1992). Since
the 1990s, ST239 has also been the most dominant nosocomial
MRSA clone in China (Aires de Sousa et al., 2003; Chen et al.,
2010).
Recent studies have explored the global epidemiology of
ST239 (Harris et al., 2010), and the contribution of other mobile
genetic elements such as sasX to the spread and survival of
this clone (Li et al., 2012). Given that there are many principle
differences between CA-MRSA and HA-MRSA, including the
typical patients and clinical infectious features (Nathwani et al.,
2008), it is most likely that the mechanism behind the infections
caused by HA-MRSA with attenuated virulence is distinct
from CA-MRSA. While MRSA ST239 is the predominant HA-
MRSA clone globally, because of its successful adaptation and
survival within the hospital environment, the factors promoting
adaptation and persistent spread in Chinese epidemic ST239
clone remain unknown. We discovered that the spa expression
of HA-MRSA ST239 is much higher than that of CA-SA ST398.
Staphylococcal Protein A (SpA), a surface-anchored conserved
structural protein expressed by all S. aureus strains, has long
been known to block opsonophagocytosis through its Fc È-
binding capacity in the presence of host antibody (Peterson et al.,
1977), as well as to bind Fab regions of the B cell receptor
(membrane-anchored IgM; Graille et al., 2000), crosslinking of
VH3 clan IgM (Goodyear and Silverman, 2003) and inducing
VH3-biased plasmablasts. The superantigen activity of SpA
leads to immunodominance, limiting host responses to other S.
aureus virulence factors (Pauli et al., 2014). SpA induces B-cell
proliferation without cytokine stimuli and the proper T-cell help
due to the anergic processes mediated by other superantigens,
leading to SpA-activated B-cell deletion and anergy (Pozzi et al.,
2015). SpA also induces early shedding of TNF-α receptor 1
(TNFR1) from phagocytic cells. The increased levels of soluble
TNFR1 present during experimental S. aureus infections may
neutralize circulating TNF-α and impair the host inflammatory
response (Giai et al., 2013). Above all, SpA plays an important
role in immune evasion in the pathogenesis of staphylococcal
infections. Here, we confirmed that the higher expression of SpA
contributes to the durable colonization and immune evasion in
ST239 clone. Furthermore, SpA may serve as a significant factor
in long-term adaptation and persistent spread of HA-MRSA
ST239 clone within hospital settings.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were performed following the Guide
for the Care and Use of Laboratory Animals of the Chinese
Association for Laboratory Animal Sciences (CALAS) and
approved by the ethics committee of Huashan Hospital,
Fudan University School of Medicine, Shanghai, China. Human
heparinized venous blood was taken from healthy individuals in
accordance with a protocol approved by the ethics committee
of Huashan Hospital, Fudan University School of Medicine,
Shanghai, China. All individuals gave written informed consent
prior to donating blood.
Bacteria and Growth Conditions
Bacteria were identified as staphylococci by classic
microbiological methods including Gram staining and catalase
and coagulase activity in rabbit plasma. S. aureus strains were
further categorized by VITEK2 automated systems (BioMérieux,
France). Community-associated S. aureus was defined as an
isolate that was obtained either from an outpatient or from
an inpatient ≤24 h after hospital admission and lacking the
following risk factors: contact with the hospital environment in
the 6 months preceding the culture, S. aureus infection history or
residence in a long-term care facility in the 12 months preceding
the culture, presence of a central vascular catheter at the time of
infection, recent antibiotic use, injection drug use; healthcare-
associated S. aureus was defined as an isolate that was obtained
from an inpatient >24 h after hospital admission or having at
least one of those risk factors. S. aureus strains used for RT-PCR
and Western-blot of SpA expression were randomly selected
from the clinical isolates with typically infectious manifestations
at Shanghai teaching hospitals in the year of 2005–2012. The
MRSA clinical isolate Ji99 (HA-MRSA ST239 strain), which
used for the development of the spamutant, was recovered from
the sputum of an inpatient with pneumonia. The isolate 1059
(the CA-SA ST398 strain) was recovered from the skin abscess
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of an outpatient at Shanghai Hospital, China. The two strains
were used for the following studies, due to their expression of
spa were in the average of both RNA and protein level. Isolates
were grown in tryptic soy broth (TSB; Oxoid, Basingstoke,
Hampshire, UK) at 37◦C with agitation and used in all animal
work. Escherichia coli TOP10 was grown in Luria-Bertani broth
(LB; Oxoid). When necessary, media were supplemented with
ampicillin (100 µg/ml) for E. coli or chloramphenicol (10 µg/ml)
for S. aureus.
Antibiotic Resistance Tests
Antimicrobial susceptibility profiles of S. aureus isolates were
determined by the agar dilution method on Mueller-Hinton
agar, according to the recommendations and definitions
from the Clinical and Laboratory Standards Institute (CLSI).
Antimicrobial agents tested were purchased from Oxoid and
included gentamicin, penicillin, cefoxitin cefazolin, levofloxacin,
erythromycin, clindamycin, trimethoprim/sulfamethoxazole
(TMP/SMX), fosfomycin, rifampicin, teicoplanin, linezolid,
and vancomycin. ATCC29213 (S. aureus) and ATCC29212
(Enterococcus faecalis) were used as quality controls.
Multi-Locus Sequence Typing (MLST)
MLST was performed as previously described (Maiden et al.,
1998). PCR amplicons of seven S. aureus housekeeping genes
(arcC, aroE, glpF, gmk, pta, tpi, and yqiL) were obtained
from chromosomal DNA. The sequences of the PCR products
were compared with the existing sequences available at the
MLST website (http://www.mlst.net), and the allelic number was
determined for each sequence.
Spa Typing
Amplification and sequencing of the polymorphic X region of
the spa gene were performed as described (Koreen et al., 2004).
The spa type was assigned using the S. aureus spa type database
(http://www.ridom.de/spaserver/).
Allelic Gene Replacement by Homologous
Recombination and Genetic
Complementation
S. aureus ST239 (Ji99)/ST398 (1059) and variants with spa
deletion were generated by allelic replacement using the pKOR1
shuttle vector (Bae and Schneewind, 2006). Briefly, 1 kb
flanking regions up and downstream of spa were amplified,
ligated, and inserted into pKOR1 using the BP Clonase II kit
(Invitrogen, Life Technologies, Carlsbad, CA, USA; Bae and
Schneewind, 2006). Recombinant plasmids were transduced
with 885 into S. aureus ST239 (Ji99)/ST398 (1059) for
integration into the chromosome and selection of deletion
mutants (Supplementary Table 1). For spa complementation,
DNA fragments were amplified with the primer pairs spa-
Sma1-F/spa-BamH1-R (Supplementary Table 2), using genomic
DNA of ST239 (Ji99) and ST398 (1059) as a template,
respectively. The amplified fragments were digested with Sma1
and BamH1 and inserted into pCL55, circularized with T4
ligase and then transformed into E. coli DH5α. Once verified,
all plasmids were given electroporation into S. aureus strain
RN4220 and subsequently transduced into the spa-deletion
mutant of S. aureus strain Ji99 (ST2391spa) with885 to generate
the complementation: Ji991spa (p239), Ji991spa (p398) and
Ji991spa (pCL55).
Nasal Colonization Model
Female BALB/c mice were used for the nasal colonization model
(eight mice per group). All mice were 6–8 weeks of age at the
time of use and received drinking water containing ampicillin
(100µg/ml). S. aureus strains were grown to the mid-exponential
growth phase, washed and resuspended in sterile PBS at 1
× 1010 CFUs per ml. Mice were anesthetized with isoflurane.
The inoculum, which contained 1 × 108 CFUs in 10 µl of
PBS or PBS alone, was pipetted slowly into the nares of the
anesthetized mice without touching the nose with the pipette
tip. Three days after inoculation, eight mice per group were
killed and evaluated for nasal carriage of S. aureus. The nasal
region was wiped externally with 70% ethanol, and nasal tissue
homogenized in 0.5 ml TSB. The total number of S. aureus
CFUs per nose was assessed by plating 100 µl diluted nasal
suspensions on TSB agar containing ampicillin (100 µg/ml;
Li et al., 2012).
RT-PCR and Western Blot of SpA
Expression
For RNA isolation, overnight cultures were diluted 1:100 in 50
ml TSB and incubated at 37◦C with shaking at 220 rpm for
8 h. Complementary DNA (cDNA) was synthesized from total
RNA using the QuantiTect reverse transcription system (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
Oligonucleotide primers were designed using Primer Express
(Supplementary Table 2). The resulting cDNA and negative
control samples were amplified using the QuantiTect SYBR green
PCR kit (Qiagen). Reactions were performed in a MicroAmp
Optical 96-well reaction plate using a 7500 Sequence Detector
(Applied Biosystems, Foster City, CA, USA). Standard curves
were determined for each gene, using purified chromosomal
DNA at concentrations of 0.005–50 ng/ml. All quantitative qRT-
PCR experiments were performed in duplicate, with gyrB as an
internal control (Li et al., 2012).
S. aureus strains were inoculated from frozen stocks into
TSB and grown overnight. The culture was diluted 1:100 and
incubated at 37◦C to post-exponential phase (8 h). Samples
were removed from cultures according to the OD600 reading
(OD600 = 2) and centrifuged at 20,000 × g for 1 min. The
cell pellet was washed with 1 mL PBS solution and suspended
in 20 µL TSM [50 mM Tris·HCl (pH 7.5), 0.5 M sucrose, 10
mM MgCl2], and placed at 37
◦C for 30 min to digest the cell
wall envelope with lysostaphin (100 µg·mL−1). The digest was
centrifuged at 20,000 × g for 1 min and the supernatant was
taken as the cell wall proteins. The proteins released to culture
were collected in supernatants and added to 1/5 volume of 100%
TCA. Samples were vortexed and incubated at−20◦C for 30 min.
Precipitated proteins were collected by centrifugation at 22,000
× g for 15 min. The supernatant was discarded, and protein
pellets were washed twice with ice-cold acetone, air-dried, and
solubilized in 25µL 4% SDS in 0.5MTris·HCl (pH 8.0), collected
as the released proteins in culture. An equal volume of SDS-
PAGE sample buffer [125 mM Tris·HCl (pH 6.8), 4% SDS, 20%
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glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue] was
added, and protein samples were boiled for 10 min. Proteins
were separated on 12% SDS-PAGE gels and electrotransferred
to a PVDF membrane. The membrane was treated in blocking
buffer (5% milk powder in PBST), followed with rabbit anti-SpA
(1:1000), then incubated at room temperature and anti-rabbit
immunoglobulin G (IgG) HRP-conjugated secondary antibody
(1:2000, Cell Signaling, Technology, Danvers, MA, USA) added.
The reactions were made visible using diaminobenzidine. To
ensure consistency between blots, SrtA was used as fractionation
control. Densitometry analysis was performed with ImageJ
software for each protein band in reference to the corresponding
sortase A band.
S. aureus Infection of Keratinocytes and
Epithelial Cells
For adhension assay, S. aureus was cultured in TSB and cell pellet
was washed twice with RPMI1640 or F12K medium (Kaighn’s
Modification of Ham’s F-12 Medium). Human immortal
keratinocytes cells HaCaT were cultured in RPMI 1640 medium
supplemented with fetal bovine serum (FBS, 10%) in T75 flasks
at 37◦C and 5% CO2. Cells were liberated from flasks using
trypsin-EDTA solution (Sigma-Aldrich, St Louis, MO, USA),
resuspended in culture medium and seeded at 2× 106 cells/well,
at a multiplicity of infection (MOI) of 100 in a final volume of 500
ul for 120 min at 37◦C with 5% CO2. Cells were washed 3 times
in RPMI 1640, and 108 CFU S. aureus were added and incubated
with the cells for 120 min. Coverslips that were used to determine
the total number of associated CFU (adherent and internalized)
were dip washed three times and subsequently lysed by the
addition of 500 µl 0.1% deoxysodium cholate solution. Bacterial
CFU were enumerated by serial dilutions of epithelial cell lysates
and plating onto TSA plates. The procedure of S. aureus infection
of epithelial cells A549 was the same as described above, except
that cells were cultured in F12Kmedium supplemented with fetal
bovine serum (FBS, 10%) and L-glutamine (2 mM).
Phagocytosis and Survival of Bacteria in
Whole Blood
S. aureus strains were grown to mid-exponential growth phase,
washed, and resuspended in sterile PBS at 108 CFU/ml. 107
CFU of S. aureus in 100 µl PBS were pipetted slowly into 10
ml heparinized blood, mixed gently for 30 s and incubated at
37◦C. Blood smears from each time point (0, 15, 30, 45, 60, and
90 min) were prepared and cells were stained with a modified
Wright-Giemsa stain. The total number of S. aureus (bound,
ingested and those within 10 µm distance of neutrophils) was
evaluated using 50 neutrophils per assay. As the clinical strains
of ST239 are highly resistant to gentamycin (Li et al., 2013),
surviving still in the existent of 100µg/ml gentamicin, calculation
of phagocytosed bacteria was not performed in gentamycin
protection assay. Percent phagocytosis was calculated using
the equation: number of ingested bacteria/
∑
(PMN-associated
bacteria, PMN-bound bacteria, ingested bacteria) × 100. To
determine survival rates, 100 µl of heparinized blood was plated
on TSA containing 5% sheep blood for S. aureus detection (Li
et al., 2012).
Infection of RAW 264.7 Cells with S. aureus
and Detection of Soluble TNFR1
RAW 264.7 cells (a mouse macrophage cell line) were cultured
in RPMI 1640 medium (Life Technologies, Grand Island, NY,
USA) supplemented with 10% FBS, 0.11 mg/ml pyruvate (Sigma-
Aldrich), 0.29 mg/ml GlutaMAX (Life Technologies), and 1 ×
nonessential amino acids (Life Technologies). RAW 264.7 cells
cultured to confluence were weaned from serum 24 h before
exposure to stimuli. S. aureus strains were grown in TSB and
suspended in RPMI 1640 medium at a concentration of 1 ×
108 CFU/ml. RAW 264.7 cells were added to prepared S. aureus
strains and centrifuged at 1000 × g for 5 min before incubation
in 5% CO2 at 37
◦C. The supernatants were collected and used
to detect soluble TNFR1 at 30, 60, and 120 min after infection
(Giai et al., 2013). Soluble TNFR1 was quantified in culture
supernatants by enzyme-linked immunosorbent assays (ELISA)
using DuoSet antibody pairs (Abcam, Cambridge, MA, USA).
Bacteriemia of S. aureus in Mouse Sepsis
Model
Overnight cultures of 10 clinical isolates S. aureus ST239
and ST398 were diluted 1:100 into fresh TSB and grown
for 4 h at 37◦C. Staphylococci were pelleted, washed, and
suspended in PBS to OD600 4 (∼1×10
9 CFU/ml). Inocula were
quantified by spreading sample aliquots on TSA and enumerating
colony formation. BALB/c mice (4–6 week old, female) were
anesthetized via inhalation with isoflurane (100 mg/ml per
kilogram of body weight). Mice were infected with 100 µl of
bacterial suspension (1× 108 CFU) by retroorbital injection and
monitored for survival.
Renal Abscess Model
Overnight cultures of S. aureus ST239-Ji99 and its isogenic
mutant were diluted 1:100 into fresh TSB and grown for 4 h
at 37◦C. Staphylococci were pelleted, washed, and suspended
in PBS to OD600 0.4 (∼1 × 10
8 CFU/ml). Mice were sublethal
challenged with 100 µl of bacterial suspension (1 × 107 CFU).
Animals were euthanized on day 7 and 15 post-infection. Both
kidneys were removed, and the staphylococcal loads in the kidney
were analyzed after homogenizing renal tissue with PBS and
0.1% Triton X-100. Serial dilutions of homogenate were spread
on TSA and incubated for colony formation. The left kidney
was examined by histopathology. Briefly, kidneys were fixed
in 10% formalin for 24 h at room temperature. Tissues were
then embedded in paraffin, thin-sectioned (4 µm), stained with
hematoxylin and eosin, and inspected by light microscopy to
observe abscess lesions. Abscess lesions were identified as foci
of infiltrated immune cells (mainly neutrophils) and/or bacterial
communities (staphylococcal abscess community; Kim et al.,
2011).
Statistical Analysis
Unpaired two-tailed Student’s t-tests were performed to analyze
the statistical significance of nasal colonization, spa expression,
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bacterial adhesion, blood survival data, ELISA data, survival rates
and bacterial loads in the experimental animal infection models.
All data were analyzed using Prism (GraphPad Software, Inc.,
La Jolla, CA, USA), and P < 0.05 were deemed statistically
significant.
RESULTS
The Nasal Colonization Rate of Clinical
HA-MRSA ST239 Isoaltes is Much Higher
than CA-SA ST398 Isoaltes
Colonization of the nares withMRSA, either present at admission
to the hospital or acquired during hospitalization, has been
proven to be a risk factor for subsequent MRSA infections
(Davis et al., 2004; Wertheim et al., 2004). ST239 is a worldwide
prevalent healthcare-acquired MRSA, and is especially dominant
in China (Li et al., 2013; Xiao et al., 2013). To explore the nasal
colonization ability of ST239, we established nasal colonization
in specific pathogen free BALB/c mice with randomly selected
clinical ST239 and ST398 strains. Prior to inoculation, mice were
administered ampicillin (all strains were ampicillin-resistant)
in their drinking water for 24 h and for the duration of the
experiment in order to reduce interference from commensal
bacterial flora. On day 3 after inoculation, nasal tissue was excised
and homogenized and the number of CFU per nose enumerated.
It was observed that there was a significant difference in the
colonized number of ST239 compared with ST398 (p = 0.0091),
suggesting that the nasal colonization of ST239 was much higher
than ST398 (Figure 1). This was in accordance with the persistent
spread caused by ST239. However, the factor promoting the
colonization of ST239 MRSA remained to be determined.
spa Expression is Elevated in Clinical
HA-MRSA ST239 Isolates, Both on the RNA
and Protein Level, Compared with CA-SA
ST398 Isolates
spa expression was analyzed using quantitative real-time RT-PCR
on a series of clinically isolated ST239 and ST398 strains with
typical infectious manifestations at Shanghai teaching hospitals
in the year of 2005–2012, 14 isolates, respectively. After 8 h of
culture, the transcription level of spa in HA-MRSA ST239 isolates
was higher than that of CA-SA ST398 isolates (Figure 2C). We
then investigated the protein expression level by western blot.
SpA is both cell wall-anchored and partially secreted into the
supernatant (Becker et al., 2014). Notably, the two components
were both detected. We found that a large proportion of HA-
MRSA ST239 strains expressed more SpA compared with CA-SA
ST398 in both cell wall and secreted fragments (Figures 2A,B),
indicating that overall HA-MRSA ST239 strains expressed more
SpA, which may contribute to the persistent colonization with
HA-MRSA ST239 strains.
SpA Improves the Nasal Colonization
Ability of S. aureus ST239
The human nose is the primary reservoir of S. aureus. Several
molecular factors of S. aureus have been identified as being
FIGURE 1 | The nasal colonization rate of clinical HA-MRSA ST239
isoaltes is much higher than CA-SA ST398 isoaltes Mice were
inoculated intranasally with clinically isolated HA-MRSA ST239 and
CA-SA ST398 isolates (1 × 108 CFU per mouse). After 3 days, mice were
euthanized and the nasal bacterial burden established. Inoculation with the
HA-MRSA ST239 isolates resulted in significantly more colonization than the
CA-SA ST398 isolates. Statistical analysis was performed using a
nonparametric t-test (n = 8 per group), **p < 0.01.
potentially responsible for nasal colonization, including teichoic
acids (Weidenmaier et al., 2004), specific surface proteins
(Wertheim et al., 2008; Corrigan et al., 2009), and immune-
modulatory factors (Jin et al., 2004; Clarke et al., 2007). SpA
is also an important factor blocking complement activation
and opsonization (Rooijakkers et al., 2005), which is detectable
at the RNA level in nasal swabs (Burian et al., 2010). This
prompted us to investigate the relationship between SpA
and nasal colonization. We constructed the 1spa mutant
strains of ST239-Ji99 and ST398-1059. Additionally, the spa
gene of Ji99 [Ji991spa(p239)] and 1059 [Ji991spa(p398)] was
complemented into the Ji991spa mutant strain, and established
nasal colonization models with wild type, the 1spa mutant and
the complemented strains. As depicted in Figure 3, colonization
of the nasal cavity was dramatically decreased with both
1spa mutant strains compared with the wild type strains,
complementation of either Ji99 spa or 1059 spa reversed the nasal
colonization of wild type ST239. Additionally, there was also a
statistical difference in the two spa deletion strains (Figure 3),
indicating that SpA is not the only factor affecting colonization
between ST239 and ST398.
SpA Improves the Keratinocyte and
Epithelial Cell Adhesion Ability of S. aureus
ST239
As SpA is a surface-associated protein within the microbial
surface components recognizing adhesive matrix molecules
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FIGURE 2 | spa expression is elevated in clinical HA-MRSA ST239
isolates, both on the RNA and protein level, compared with CA-SA
ST398 isolates. (A) Clinical HA-MRSA ST239 and CA-SA ST398 isolates
were cultured for 8 h then centrifuged to separate the extracellular protein A
(marked as “S”) from the bacterial cell wall-associated protein A (marked as
“W”). After treatment of the staphylococcal cell wall envelope with lysostaphin,
proteins in both fractions were analyzed by immunoblotting with polyclonal
antibodies against protein A. The original gels are provided in the
Supplementary Figure 1. (B) Semiquantitative densitometry analysis of each
protein band in reference to the corresponding sortase A band was performed
using ImageJ software. (C) RNA transcripts were quantified in reference to the
transcription of the housekeeping gene gyrB at 8 h (post-exponential phase)
cultures of clinical HA-MRSA ST239 and CA-SA ST398 isolates. Each dot
represents a different strain. Statistically significant differences between ST239
and ST398 are indicated: *p < 0.05, ***p < 0.001
(MSCRAMMs) family (Speziale et al., 2009), we wondered
if this protein also played a role in the interaction with
keratinocytes and epithelial cells. The spa mutant (Ji991spa,
10591spa) and complemented strains [Ji991spa(p239),
Ji991spa(p398)] were constructed, with the pCL55 vector
complement [Ji991spa(pCL55)] being used as a control. The
expression of SpA in the complement strains were verified by
western-blot (Figure 4A). All strains were added to cultured
human keratinocytes (HaCaT) and lung epithelial cell (A549)
FIGURE 3 | SpA improves the nasal colonization ability of S. aureus
ST239. Mice were inoculated intranasally with WT ST239-Ji99, ST398-1059,
their 1spa mutant strains (Ji991spa, 10591spa) and complemented strains
[Ji991spa(p239), Ji991spa(p398)] (1 × 108 CFU per mouse). After 3 days,
mice were euthanized and the nasal bacterial burden determined. Statistical
analysis was performed using a nonparametric t-test (n = 8 per group),
**p < 0.01.
monolayers for 2 h to measure the attachment of bacteria. As
expected, the number of attached and internalized wild type
Ji99 bacteria was greater than the number of 1059 bacteria,
and both were markedly decreased in the spa deletion strains.
The complement strains of SpA from either ST239(Ji99) or
ST398(1059) could reverse the bacteria adhension ability
(Figure 4B). It was likely that the difference between the two
clinical strains had little connection with the different spa gene
structures. These results suggested that protein A enhanced the
keratinocytes and epithelial cells adhesion of HA-MRSA ST239
strains and promoted the colonization in return. The statistical
difference in the two spa deletion strains indicated that SpA was
not the only factor affecting the bacteria adhesion (Figure 4B).
Resistance to Phagocytosis is Decreased
in the ST239 1spa Strain
Neutrophils play a central part in protecting humans against S.
aureus infection. Staphylococcal entry and replication in host
tissues lead to the release of bacterial products that produce
inflammatory signals. Neutrophils answer this call, extravasating
from blood vessels, migrating toward the site of infection to
phagocytose and kill bacteria or to immobilize and damage
the pathogen (Thammavongsa et al., 2015). When confronted
with neutrophils, most bacteria are more easily phagocytized in
comparison with S. aureus. The liberated SpA together with the
wall-anchored could interact with FcÈ region of IgG (Peterson
et al., 1977) via the IgG-binding domains (Deisenhofer, 1981),
coating the surface of the cell with IgG molecules unable to
be recognized by the neutrophil Fc receptor and blocking the
neutrophil’s phagocytosis of S. aureus. Furthermore, protein
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FIGURE 4 | SpA improves the keratinocyte and epithelial cell adhesion ability of S. aureus ST239. (A) Anti-SpA western-blot of WT bacteria, 1spa mutant,
1spa mutant complemented with the ST239 spa gene [1spa(p239)], ST398 spa gene [1spa(p398)], or vector [1spa(pCL55)]. (B) Colony counts of adhesive and
internalized bacteria above in HaCaT keratinocytes and A549 epithelial cells infected for 2 h. An ∼0.25-fold increase could be seen for ST239 compared with ST398
and ∼1-fold increase compared with the 1spa mutant. Statistical differences were determined by one-way ANOVA with Tukey’s multiple-comparison test, *p < 0.05,
**p < 0.01, ***p < 0.001. Data are representative of three independent experiments.
A-rich strains are phagocytized more slowly than strains with
low expression of protein A (Peterson et al., 1977). Therefore, we
investigated the antiphagocytic effect of protein A in WT ST239-
Ji99 with high levels of protein A and the1spamutant strain with
no protein A. After 15 min of incubation with normal human
whole blood, the1spamutant strain underwent a greater degree
of phagocytosis than WT (p < 0.0001). This effect could also be
seen at 30 min of incubation (p = 0.0031), as seen in the blood
smear from 15–45 min after phagocytosis (Figures 5A,B). The
complementation of Ji99 spa gene and 1059 spa gene resulted
in the same survival rate in human blood as the Ji99 WT after
15 min of phagocytosis, which was much higher than the 1spa
mutant (Figure 5C). The higher anti-phagocytosis capacity of
ST239, largely due to its high expression of protein A, increased
its immune evasion from host immune cells.
Protein A Attenuates the Inflammatory
Response Caused by ST239 Through Early
Shedding of TNFR1
Evading the host immune response is a vital strategy to enable
duration in S. aureus infection. Protein A plays another key
role in subverting the host immune response through its ability
to induce early shedding of TNF-α receptor 1 (TNFR1). The
increased levels of soluble TNFR1 present during experimental
S. aureus infection may neutralize circulating TNF-α and impair
the host inflammatory response (Giai et al., 2013). Among the
proinflammatory cytokines induced, TNF-α has been shown to
be crucial for the eradication of bacteria in other experimental
models (Nakane et al., 1995). As for our clinical ST239 isolates
with high expression of protein A, the specific mechanism
involved remained to be elucidated. We hypothesized the lower
virulence of ST239 may be due to the higher expression of SpA,
which could attenuate the inflammatory response. Therefore, the
kinetics of TNFR1 shedding in response to whole live clinical
isolates of S. aureus ST239 and ST398 was investigated in
macrophages.
Shedding of TNFR1, as well as an obvious distinction between
ST239 and ST398 strains, occurred as soon as 30 min after
exposure of macrophages to S. aureus. The difference in shedding
was even larger at 120 min exposure (Figure 6A). With the
1spamutant, there was much less TNFR1 shedding compared to
WT ST239-Ji99. When the spa gene was complemented into the
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FIGURE 5 | Resistance to phagocytosis mediated by protein A is enhanced in the HA-MRSA ST239 strains. (A) Phagocytosis assay. Phagocytosis by
human neutrophils of ST239 or the 1spa mutant bacteria was examined by light microscopy. Significant differences were seen at 15 and 30 min incubation. (B)
Microscopic examination of phagocytosis. Slides were stained using a modified Wright-Giemsa stain at 0, 15, 45, and 90 min. There were fewer phagocytized S.
aureus ST239 bacteria in neutrophils compared with the mutant strain from 15–45 min. (C) Survival in human blood at t = 15 min (Other time such as 30 and 45 min
time points are statistically significant, but not that much compared to the 15 min time point). Statistically significant differences are indicated, **p < 0.01, ***p < 0.001.
mutant, either Ji99 spa or 1059 spa, TNFR1 shedding returned to
the WT level from 30 to 120 min after infection (Figures 6B–D).
Thus, the TNFR1 shedding effect of protein A was greater in
ST239, constituting a crucial step in immune evasion of S. aureus
infections.
SpA May Contribute to the Durative
Damage in Host Infected with HA-MRSA
ST239
SpA contributes to S. aureus virulence in infections such
as arthritis and sepsis (Palmqvist et al., 2002). Resistance to
methicillin of HA-MRSA affects bacteria’s agr sensing system,
leading to reduced virulence and inability to move into the
community, while the emergent community-associated MRSA
(CA-MRSA) typically express less penicillin-binding protein 2a
(encoded by mecA), allowing them to maintain full virulence and
succeed in the community environment (Rudkin et al., 2012).
In order to test the infection mortality between the epidemic
HA-MRSA ST239 of high SpA expression and CA-SA ST398, an
acute sepsis model was developed in BALB/c mice. Groups of
mice were inoculated intravenously with clinical ST239 or ST398
isolates. The ST398 strains gave rise to a significantly higher
(p< 0.001) mortality rate than ST239 (Figure 7A). The mortality
of ST239 was relatively lower than ST398.
The CA-SA ST398 could produce multitudes of external
toxins, enhancing its invasive ability and easily causing the more
severe infections in healthy individuals, while ST239 produce
higher amounts of protein A. To explore the higher expression
of protein A in the pathogenicity of ST239 infections, we then
developed a mouse renal abscess model with sublethal challenged
bacteriaWT Ji99 and its isogenic spamutant strain, and evaluated
the severity of infection by enumerating staphylococcal CFU per
kidney. Both 7 and 15 days after inoculation, the staphylococcal
loads per kidney were decreased in the 1spa mutant-infected
mice compared with the WT-infected mice (Figure 7B). Tissue
damage in development of abscess formation in kidneys of
the mutant-infected mice was also alleviated contrast to the
WT-infected mice (Figures 7C′–E′). These data suggested that
protein A was a prominent factor working in abscess lesions,
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FIGURE 6 | Protein A induces early shedding of TNFR1, attenuating the inflammatory response after infection with HA-MRSA ST239. RAW 264.7 cells
were stimulated with the clinical isolates HA-MRSA ST239, CA-SA ST398 (A) or wild-type ST239-Ji99, the 1spa mutant and complemented strains (B–D) for the
times indicated. The concentration of sTNFR1 was determined by ELISA. Data are means and standard deviations of cumulative data from three independent
experiments (n = 3 for each experiment). Asterisks indicate significant differences (**p < 0.01) by a nonparametric t-test.
contributing largely to the durative damage with HA-MRSA
ST239 infection.
DISCUSSION
S. aureus is a common pathogen contributing to multitudes of
infections. MRSA, responsible for innumerable drug-resistant
healthcare-associated infections globally, has evolved with
progressive adaptation to its environment. Recent studies have
demonstrated the crucial adaptive responses of HA-MRSA to
the highly selective environment of the healthcare system, and
the evolution of HA-MRSA isolates to even higher levels of
antibiotic resistance at the cost of attenuated virulence (Baines
et al., 2015), which improves its ability to become a successful
nosocomial pathogen. High expression level of mecA in HA-
MRSA affects bacteria’s agr sensing system, leading to reduced
virulence and inability to move into the community, while
the emergent CA-MRSA typically express less penicillin-binding
protein 2a (encoded by mecA), allowing them to maintain full
virulence and succeed in the community environment (Rudkin
et al., 2012). HA-MRSA strains are less virulent as a direct
consequence of expressing the mecA gene at high levels (Rudkin
et al., 2012) in addition to the expression of psm-mec, a putative
virulence regulatory locus as well as a cytolytic phenol-soluble
modulin having been identified on the healthcare-associated type
II SCCmec element (Queck et al., 2009; Kaito et al., 2011).
In our study, we focused on the global spread HA-MRSA
ST239, the predominant hospital infection in China for decades
and quite distinct from the emerging CA-SA ST398 infecting
healthy populations with no contact to healthcare settings and
no association with animals (Zhao et al., 2012). To investigate
what enables HA-MRSA ST239 to successfully colonize in a
hospital setting and gradually progress to a series of widespread
invasive infections, we searched for additional contributing
factors, other than the existent expression of psm-mec and mecA
that attenuate virulence and promote its spread in nosocomial
settings. We discovered higher expression of protein A by HA-
MRSA ST239 compared with CA-SA ST398. Notably, protein
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FIGURE 7 | SpA contributes to the durative damage in host infected with HA-MRSA ST239. (A) Percentage of surviving mice in mice sepsis model challenged
with 1 × 109 CFU of clinically isolated ST239 and ST398. The mortality over the experimental period was significantly lower for mice infected with HA-MRSA ST239
compared to those infected with CA-SA ST398 strains, as assessed by a log rank test (p < 0.05 after Bonferroni correction for multiple testing. n = 10/group). (B)
Cohorts of BALB/c mice (n = 8–10) were treated by injection into the retroorbital plexus with either 1 × 108 CFU of S. aureus ST239 or the 1spa mutant. On day 7 or
15 postchallenge, animals were killed to enumerate staphylococcal burden in renal tissues. No mortality was observed during the sublethal challenge. (C-E′)
Representative hematoxylin and eosin stained histopathology slides of the kidney on day 15 postchallenge. White arrows indicate staphylococcal abscess
communities. Histopathology images were acquired with light microscopy at × 40 (C–E) and × 200 (C′–E′) magnification. Scale bars represent 100 µm (C–E) and
25 µm (C′–E′) respectively. Animal data are representative of 3 independent experiments. *p < 0.05, ***p < 0.001.
A, a highly conserved protein expressed by all S. aureus
isolates, is an important immunomodulatory factor blocking
opsonophagocytosis through the Fc È-binding domain and
inducing B cell apoptosis by binding to the Fab domains and
crosslinking of VH3 clan IgM in B cells. To a large extent, SpA-
neutralizing antibodies cannot be developed during infections.
The superantigen activity of SpA leads to immunodominance,
limiting host responses to other S. aureus virulence factors (Pauli
et al., 2014). SpA may constitute a crucial determinant in the
colonization and spread of the epidemic HA-MRSA ST239 clone
in hospital settings.
Protein A, a cell wall-anchored protein, can also be released
into the extracellular surroundings to access the host’s immune
system (Becker et al., 2014). spa is expressed by all clinical
S. aureus isolates with conserved immunoglobulin binding
domains. However, its expression in different clones may be of
much diversity as shown in our study. SpA is also detectable at the
RNA level in nasal swabs (Burian et al., 2010). The exoproteome
of a nasal carrier strain of S. aureuswas compared to a genetically
similar non-carrier strain, revealing that Staphylococcal protein
A was present at significantly higher levels in carrier strains than
the non-carrier, which suggests an association of protein A with
nasal carriage (Muthukrishnan et al., 2011). We observed that
increased expression of protein A in HA-MRSA ST239 enhanced
nasal colonization of this clone. The mechanism behind the
colonization promotion may be the sequentially glycosylation of
SpA in nasal carrier strains, while glycosylation of exoproteins
such as SpA might play crucial roles in bacterial pathogenesis
and immunoevasion (Schmidt et al., 2003; Muthukrishnan et al.,
2011). Other than nasal cavity, S. aureus colonize in skin,
armpits and crissum. The colonization may be associated with
the interaction between SpA and epidermal keratinocytes. There
are studies discovering the important role of protein A for the
staphylococcal adhesion to human epidermal cells (Cole and
Silverberg, 1986; Mempel et al., 1998). This was confirmed by
the low adhesion capacity of protein A-negative mutant Ji991spa
and 10591spa strains to the cultured monolayers. Its counterpart
on human keratinocytes may be cytoskeletal β-actin. The binding
of SpA to mammalian epithelial actin filaments plays a role in
the internalization and dissemination of S. aureus (Jung et al.,
2001). We then tested this binding affinity of SpA in the human
epithelial cells, which is involved in the regulation of S. aureus
invasion by epithelial cells with the elongation of actin filaments
by their polymerization. Here we see that the increased SpA
of ST239 enhanced the adhesion to keratinocytes, as well as
epithelial cells. And it helps to promote the colonization of ST239
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in human in the way of positive feedback. Additionally, the two
spa deletion strains of ST239 and ST398 were seen statistically
different in colonization and adhesion, indicating that there are
other factors involved in this process except protein A.
Risk factors for S. aureus infection include recent surgery,
admission to a hospital or nursing home, antibiotic use, dialysis,
and permanent indwelling catheter (Nathwani et al., 2008).
Upon entering the host, HA-MRSA ST239 defends against the
immune response by early resisting neutrophils’ phagocytosis
and inducing activated-B cell apoptosis through the expression of
surface-anchored and released SpA, suppressing the production
of neutralizing antibodies against SpA and many other antigens,
which facilitates its dissemination from sites of infection to other
regions.
Previous studies have demonstrated that endogenous TNF
plays an important role in host resistance to S. aureus infection,
while endogenous IFN-È provides protection in the early stage of
infection and plays a detrimental role late in infection (Nakane
et al., 1995). TNF has been shown to alter many properties of
neutrophils in vitro: enhancement of phagocytosis, induction
of degranulation, stimulation of adherence, and stimulation of
the generation of superoxides. Mice lacking capacity to produce
TNF-α have highermortality and inefficient bacterial clearance in
S. aureus arthritis and brain abscess model (Hultgren et al., 1998;
Kielian et al., 2004). Protein A recognizes TNFR1 on epithelial
cells and induces inflammation through TNFR1 in the way
of TNF-α-TNFR1 signaling activation, leading to recruitment
and activation of neutrophils and bacterial clearance from the
airway, though at the cost of PMN-associated epithelial damage
and respiratory compromise (Gomez et al., 2004). Protein A
plays another key role in inducing early shedding of TNFR1
on macrophages. The increased levels of soluble TNFR1 present
during systematic HA-MRSA ST239 infection may neutralize
circulating TNF-α and impair the host inflammatory response
(Giai et al., 2013). The combination of anti-TNF-α drugs and
antibiotic alleviates the outcome of S. aureus arthritis and
sepsis in a mouse model (Fei et al., 2011; Ali et al., 2015).
The action of soluble TNFR1 much resembles the anti-TNF-α
drugs, suggesting that blocking TNF-α indeed increases bacterial
survival in infections and benefits the host by decreasing the
damage caused by inflammation. Perhaps that also partially
explains why ST239 seem to be less virulent and can colonize
hosts for a longer time. It is a novel strategy for ST239 subverting
the host immune response. The TNFα-TNFR1 regulation is more
complicated after S. aureus infection in vivo, depending largely
on the type and stage of diseases, and differs in localized and
systemic infections (Giai et al., 2013). Then we need to do more
experiments to elucidate the process in our following studies.
There is a difference in spa gene structure between ST239
and ST398 clones: the length of spa gene in ST239 is shorter
than that of ST398, which mainly exists in Domain D, Domain
A and Xr region. Does the difference between the two clinical
strains have connection with their different spa gene structures,
other than different levels of protein A production? To address
the question, we constructed the two spa complemented strains:
Ji991spa(p239) complemented with the ST239 spa gene and
10591spa(p398) with ST398 spa gene. The Western Blot data
showed that the expression of protein A in Ji991spa(p239) and
10591spa(p398) were almost in the same level (Figure 4A).
Furthermore, the two spa complemented strains can reverse
the phenotypes, including the nasal colonization in mice,
the adhesion ability to cells, anti-phagocytosis and TNFR1
shedding, to the wild type level (Figures 3, 4B, 5C, 6B–D),
suggesting that the difference is not due to the distinct spa
structures between ST239 and ST398 but the expression of this
protein.
Protein A also acts as a virulence factor in S. aureus infections
and is necessary for the development of abscess formation
(Palmqvist et al., 2002; Cheng et al., 2009). Palmqvist et al.
reported the elevated levels of TNF-α in infections is caused
by protein A-deficient mutants, which is in consistent with our
results about SpA shedding of TNFR1 on macrophages. In the
acute sepsis model (with high bacterial load: 1 × 109 CFU),
the mortality caused by ST239 was significantly lower than
ST398 (Figure 7A), suggesting that SpA may contribute to the
low mortality in ST239 infections with higher SpA expression
rather than the acute infection caused by CA-ST398, while the
production of a plethora of external toxins in ST398may enhance
its pathogenicity. According to the report of Cheng et al. SpA
is necessary for the development of abscess formation. We then
tested the function of SpA by using sublethal dose of bacterial
infection (with low bacterial load: 1× 108 CFU) challenged with
ST239, along with its isogenic spa mutant strain, and observed
its role in tissue abscess formation. Our data suggested that SpA
exactly promoted the durative damage in renal, as the isogenic
spa mutant strain of ST239 had relatively lower bacterial load
and alleviated tissue damage in kidney (Figures 7B–E′). All of
above data suggest that SpA is not a key virulence factor in acute
infections of S. aureus, it may contribute to the durative damage
in host infected with HA-MRSA ST239.
Protein A is an exceptional virulence factor, a single
protein that can target multiple immunologically important
eukaryotic receptors. Probably, it is not a coincidence that
protein A is amongst the most highly conserved staphylococcal
virulence factors expressed, nor that its levels of expression are
significantly increased in staphylococci isolated from invasive
human infections (Gomez et al., 2007). To summarize, we
suggest that protein A may serve as a crucial determinant
in the colonization and immune evasion of HA-MRSA ST239
infections, thus contributing to persistent spread in the hospital
settings.
The highly successful adaptive HA-MRSA ST239 is a growing
concern worldwide. The combination of anti-TNF-α drugs and
antibiotic may have little use in the treatment therapy against
ST239 infections. Researchers have focused on immunization
with non-toxigenic protein A (SpAKKAA) or administration
of protein A-neutralizing monoclonal antibodies, thus eliciting
protective antibodies in mice against highly virulent MRSA
strains (Kim et al., 2010, 2012). Furthermore, it has been
proposed that SpAKKAA represents a protective antigen for the
development of a staphylococcal vaccine (Falugi et al., 2013). We
hope that the vaccine could inform novel prevention policies in
health care settings, and the development of new antibodies to
treat HA-MRSA infections.
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